产品搜索 抗体高级搜索

首页 > 产品列表 > 一抗 > 免疫学

Aldh1A1 antibody

产品编号:2293-1

产品描述:Aldh1A1 antibody

反应种属:Human

实验方法:WB, IHC

标记:

规格:100ul

供应商:Epitomics

价格(RMB):2500.00

订购:订购

说明书:

Aldh1A1 antibody

Cat.#: 2293-1

Rabbit Monoclonal Antibody

Clone ID: EP1932Y
Swiss Prot: P00352
Mol Weight: 55kDa
Size: 100ul
Description

Acetaldehyde dehydrogenase (ALDH) is the next enzyme after alcohol dehydrogenase in the major pathways of alcohol metabolism. Usual human livers contain two major ALDH isozymes, i.e., cytosolic ALDH1 and mitochondrial ALDH2(1). Human red cell aldehyde dehydrogenase (ALDH) resembles the liver cytosolic isozyme in numerous physicochemical properties. Thus, the erythrocyte enzyme, by virtue of its chemical and structural identity with the liver cytosolic enzyme, may serve as a suitable peripheral enzyme model to understand the cause and mechanism of alcohol abuse-related changes in liver cytosolic ALDH that has been found to be reduced in alcoholics (2). ALDH1A1 is known to catalyze the oxidation of retinaldehyde to retinoic acid. Overexpression of human ALDH1A1 in HEK cells led to a more than 20-fold increase in 3-deoxyglucosone dehydrogenase activity (3).

Recommended Applications

WB, IHC

Applications and Recommended Dilution Factors

WB: 1:1000
IHC: 1:100 - 250

Species Reactivity

Human


Products Data


A. Western blot analysis on HepG2 cell lysate using anti-Aldh1a1 RabMAb (cat. # 2293-1), dilution 1:1000.

B. Immunohistochemical analysis of paraffin-embedded human liver using anti-Aldh1a1 RabMAb (cat. #2293-1).
  

Specificity

A synthetic peptide corresponding to residues in human ALdh1a1 was used as an immunogen.

Storage Buffer & Conditions

50 mM Tris-Glycine (pH 7.4), 0.15 M NaCl, 40% Glycerol, 0.01% sodium azide and 0.05% BSA.

Alternative Names

ADH1B, ADH2, Alcohol dehydrogenase 1B, Alcohol dehydrogenase subunit beta

Description References

1. Yoshida A, et al. Alcohol 2(1):103-6, 1985
2. Agarwal DP, et al. Enzyme 42(1):47-52, 1989
3. Collard F, et al. Biochimie 89(3):369-73, 2007

Product References

1. Zou D, Yoon HS, Anjomshoaa A, et al, Increased levels of active c-Src distinguish invasive from in situ lobular lesions ,Breast Cancer Res 11 (2009) R45
[Application: IHC]